The site uses anonymous third party analytic cookies: in accessing any element/area of the site outside of this banner, you consent to receiving cookies.

[Instant Insights] NHS reorganisation

In our latest Instant Insights post, Oli Hudson explores the implications of NHS England's pre-legislative proposals to reshape the regional...

Shaping the organisation to enable intelligent, precision engagement

Covid-19 has accelerated by three to five years the need to create the optimal blend of face-to-face sales resource and digital channels, to suit...

Building the trust – post COVID-19

Simon Grime, Executive Director at Wilmington Healthcare discusses what needs to be done to build trust between pharma and health in a post COVID-19...

[Download]: Covid-19: Roadmap to Recovery

The pandemic response in the UK has now moved on to ‘phase 3’, setting out a gradual return to pre-Covid NHS service levels The NHS is drawing...

How will MedTech recover in the Recovery?

Transforming partnership with the NHS, an agile approach to regulation, and accelerating patient access to new and improved treatments, will be of...

The NHS in the time of covid: what happens next

What will the next six months bring for the NHS HSJ has spoken to the service’s most senior figures and makes the following...

How has Covid-19 changed the MedTech NHS customer landscape?

Oli Hudson, content director at Wilmington Healthcare, explores the rapid and startling changes to the NHS customer landscape – and how it will...

CCG mergers drive integrated care agenda

Oli Hudson, of Wilmington Healthcare, assesses the latest tranche of Clinical Commissioning Group (CCG) mergers and what they mean for industry...

New rules of engagement

Healthcare systems have changed forever as a result of Covid-19 Simon Grime, of Wilmington Healthcare, examines how pharma should respond to the new...

COVID-19 and the critical role of MedTech

COVID-19 is changing the face of healthcare at an unprecedented pace We examine the key role MedTech has in tackling the virus, how to tackle some of...

Delivering true value: what does it mean for KAM in cancer care?

Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the...

Value-based procurement: could it become a reality?

Oli Hudson, content director at Wilmington Healthcare, looks at value-based procurement and its place in procurement in the emerging NHS...

Latest Tweets from @Wilmhealthcare